Microfluidic devices enable rapid, automated processing and manipulation of multiple sample populations without cross-contamination, enhancing experimental throughput and quality for model organisms like C. elegans.
Background
Microfluidic technology has emerged as a critical field within biomedical and biochemical research, offering precise control and manipulation of small fluid volumes on a microscale. This technology is particularly valuable for applications requiring high-throughput screening, diagnostics, and the study of model organisms like C. elegans.
The need for such technology arises from the growing demand for rapid, automated, and accurate sample processing in various scientific and medical fields. Traditional methods often involve manual handling and processing, which are time-consuming, prone to human error, and limited in throughput. Microfluidic devices address these limitations by enabling automated and high-precision manipulation of samples, thus accelerating research and improving the reliability of experimental results.
Despite the advancements, current approaches to microfluidic sample processing face significant challenges. One major issue is the potential for cross-contamination between different sample populations, which can compromise the integrity of experimental data. Additionally, many existing systems lack the ability to process individual members of a sample population rapidly and automatically, limiting their effectiveness in high-throughput applications.
These limitations can result in slower processing times, reduced accuracy, and lower overall throughput, hindering the progress of research that relies on the meticulous study of small organisms or cellular samples. Consequently, there is a pressing need for more advanced microfluidic systems that can overcome these challenges and provide reliable, high-throughput sample processing without the risk of contamination.
Technology description
Microfluidic devices are designed for the rapid and automated processing of sample populations. These devices include multiplexer microfluidic systems that can serially deliver multiple distinct sample populations to a processing element quickly and automatically, ensuring no cross-contamination between the different samples. Additionally, these devices feature microfluidic sample processing elements capable of rapidly and automatically manipulating or interrogating individual members of a sample population. These advancements enhance the throughput and quality of experiments involving model organisms, such as C. elegans.
What differentiates this technology is its ability to handle multiple samples in a highly efficient and contamination-free manner. The multiplexer microfluidic systems streamline the delivery process, significantly reducing the time required for sample processing. The automated nature of these devices minimizes human intervention, thereby reducing the potential for errors and increasing the reproducibility of experiments.
Furthermore, the capability to manipulate or interrogate individual members of a sample population allows for more detailed and precise experimental outcomes. These features collectively make microfluidic devices a powerful tool in biological research, particularly in studies involving model organisms.
Benefits
- Rapid and automated processing of sample populations
- Ensures no cross-contamination between different samples
- Enhances throughput and quality of experiments
- Capable of manipulating or interrogating individual sample members
Commercial applications
- Automated diagnostic testing
- High-throughput drug screening
- Genetic research
- Biomedical research
Patent links
https://patents.google.com/patent/US10052631B2/en?oq=+10%2c052%2c631
https://patents.google.com/patent/US11192109B2/en?oq=+11%2c192%2c109